Singapore, March 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-2)'. The following are the other relevant details related to the trial:
Therapeutic Area: Ophthalmology
Trial Centre(s):
Singapore National Eye Centre
Tan Tock Seng Hospital
Trial Status: Ongoing, Recruiting
Principal Investigator(s):
Dr Gemmy Cheung
Dr Nicola Gan
Published by HT Digital Content Services with permission from Health Daily Digest....